These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21305670)

  • 1. Concise review: culture mediated changes in fate and/or potency of stem cells.
    Roobrouck VD; Vanuytsel K; Verfaillie CM
    Stem Cells; 2011 Apr; 29(4):583-9. PubMed ID: 21305670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.
    Balasubramanian S; Babai N; Chaudhuri A; Qiu F; Bhattacharya S; Dave BJ; Parameswaran S; Carson SD; Thoreson WB; Sharp JG; Rao M; Ahmad I
    Stem Cells; 2009 Dec; 27(12):3053-62. PubMed ID: 19859985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro models of intestinal epithelial cell differentiation.
    Simon-Assmann P; Turck N; Sidhoum-Jenny M; Gradwohl G; Kedinger M
    Cell Biol Toxicol; 2007 Jul; 23(4):241-56. PubMed ID: 17171431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
    Sanges D; Cosma MP
    Int J Dev Biol; 2010; 54(11-12):1575-87. PubMed ID: 21305473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct generation of pluripotent stem cells from differentiated somatic cells].
    Li L; Guan W; Ma Y; Li H; Bai X; Gong X
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1695-701. PubMed ID: 19149179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular reprogramming of somatic cells.
    Sumer H; Liu J; Verma PJ
    Indian J Exp Biol; 2011 Jun; 49(6):409-15. PubMed ID: 21702219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced adult stem (iAS) cells and induced transit amplifying progenitor (iTAP) cells-a possible alternative to induced pluripotent stem (iPS) cells?
    Heng BC; Richards M; Ge Z; Shu Y
    J Tissue Eng Regen Med; 2010 Feb; 4(2):159-62. PubMed ID: 19967742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed growth and differentiation of stem cells towards neural cell fates using soluble and surface-mediated cues.
    Boote Jones EN; Mallapragada SK
    J Biomater Sci Polym Ed; 2007; 18(8):999-1015. PubMed ID: 17705995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials for stem cell differentiation.
    Dawson E; Mapili G; Erickson K; Taqvi S; Roy K
    Adv Drug Deliv Rev; 2008 Jan; 60(2):215-28. PubMed ID: 17997187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of murine and porcine fetal stem cells from somatic tissue.
    Kues WA; Petersen B; Mysegades W; Carnwath JW; Niemann H
    Biol Reprod; 2005 Apr; 72(4):1020-8. PubMed ID: 15616223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and multipassage culture of human fetal kidney epithelial progenitor cells.
    Loo D; Beltejar C; Hooley J; Xu X
    Methods Cell Biol; 2008; 86():241-55. PubMed ID: 18442650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.